This FOXP4 downregulation‐induced squamous differentiation was regulated through an ELF3‐dependent pathway, suggesting that FOXP4 is a target molecule for differentiation therapy of CIN.11 This evidence concerns the gene ELF3 and cervical squamous intraepithelial neoplasia.